Delivery Order SPE2DR25D2206-SPE2DR26F0BUP

<p>The Defense Logistics Agency issued a $56,503.48 delivery order to Amerisourcebergen Drug Corp on March 17, 2026, for Ultomiris 300 mg/3 mL vials under a firm fixed-price arrangement.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion on April 7, 2026. No set-aside was used in the award.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for Ultomiris 300 mg/3 mL vials with a ceiling value of $25,683.40 and an ultimate completion date of March 23, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is issued under firm fixed-price terms with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a $28,251.84 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Ultomiris 1,100 mg/11 mL vials under firm fixed-price terms.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is April 15, 2026. No set-aside applies to this order.</p>

<p>The Defense Logistics Agency issued a $28,251.84 delivery order to AmerisourceBergen Drug Corp on March 31, 2026, for supply of Ultomiris 1,100 mg/11 ml vials.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and extending through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is April 21, 2026. Pricing is firm fixed price. No set-aside applies.</p>

The Defense Logistics Agency issued a $59,072.02 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Ultomiris 1,100 mg/11 ml vials, with an ultimate completion date of April 15, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. Pricing...

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 13, 2026, for Ultomiris (pecirilumab) 300 mg/3 mL vials, with a ceiling value of $56,503.48 under firm fixed-price terms. Place of performance is Conshohocken, PA. The order has an ultimate completion date of May 4, 2026. No set-aside was applied. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up...

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 10, 2026, with a ceiling value of $28,251.74 for the supply of Ultomiris 300 mg/3 mL vials. Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 18, 2026, with a ceiling value of $51,366.80 for Ultomiris 300 mg/3 ml vials.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order is priced firm fixed price with an ultimate completion date of March 11, 2026.</p>

The Defense Logistics Agency awarded a delivery order valued at $10,273.36 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Ultomiris 300 mg/3 ml vials. This competitively awarded, firm fixed price contract is scheduled for completion by January 27, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger...

<p>The Defense Logistics Agency issued a $56,503.68 delivery order to Amerisourcebergen Drug Corp on January 7, 2026, for Ultomiris (pegloticase) 1,100 mg/11 ml vial pharmaceutical supply, with ultimate completion on January 29, 2026.</p> <p>The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA.</p>